Iran is currently experiencing a severe shortage of essential medications, affecting hundreds of life-saving drugs. The crisis is driven by a combination of intense international sanctions, a naval blockade, and direct military strikes on domestic pharmaceutical facilities. According to industry representatives, hundreds of pharmaceutical products are in short supply, with prices for common treatments like insulin and antibiotics surging significantly. The destruction of key manufacturing sites, such as Tofigh Daru, has further crippled the country's ability to produce critical medical supplies. While Iranian officials maintain that the sector remains resilient and is working to overcome these obstacles, medical professionals express deep concern regarding the long-term impact on public health. The situation is compounded by broader economic inflation, making essential healthcare increasingly unaffordable for many citizens who are struggling to find reliable alternatives to imported medications.
Source : Al Jazeera English
Aussi couvert par : Al Jazeera English
